EFFECT OF 12 WKS OF COLESEVELAM ON INSULIN SENSITIVITY & ORAL GLUCOSE ABSORPTION

12 周考来维仑对胰岛素敏感性的影响

• 批准号: 7724920
• 负责人: Robert Roy Henry
• 金额: $ 2.61万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724920
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Daily; Funding; Glucose; Grant; Hepatic; Institution; Non-Insulin-Dependent Diabetes Mellitus; Oral; Peripheral; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Week; absorption; colesevelam; glycemic control; insulin sensitivity

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. In subjects with Type 2 diabetes with inadequate glycemic control on oral therapy study 1. Evaluate the effect of colesevelam 3.8 g administered daily for 12 weeks, on hepatic insulin sensitivity. 2. Evaluate the effect of colesevelam 3.8g administered daily for 12 weeks on peripheral insulin sensitivity.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 口服治疗研究中血糖控制不佳的2型糖尿病受试者 1. 评价每天给予3.8 g考来维仑持续12周对肝脏胰岛素敏感性的影响。 2. 评价考来维仑3.8 g每日给药持续12周对外周胰岛素敏感性的影响。